Actively enrolling
Study overview
30+patients
30 monthsmean follow-up (longest beyond 48 months)
Multicenterfirst-in-human, single-arm safety and feasibility study
NCT05230745ClinicalTrials.gov
The first procedure in the study was performed in Belgium in 2021. The device is used in this study under the name ContraBand™.
Scientific Advisory Board
